HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oral Contraceptive Rx-to-OTC Switch On The Cusp In UK

Executive Summary

The MHRA is consulting on two Rx-to-OTC switch applications for progestogen-only contraceptive pills containing desogestrel, one from HRA Pharma and one from Maxwellia. The move has been welcomed by UK consumer healthcare industry association, the PAGB, as well as the British Pregnancy Advisory Service. 

You may also be interested in...



UK's Maxwellia Looking Into Daily Contraceptive Rx-To-OTC Switch

As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects. 

Growing Clamor For Oral Contraceptive OTC Switch In UK

UK parliamentarians have added their voice to the growing calls for the MHRA to switch the daily oral contraceptive pill to OTC status. The COVID-19 pandemic has further highlighted the difficulties women face in accessing contraception, according to the politicians. 

Make Emergency Contraceptives GSL In The UK, Urge HRA Pharma And The British Pregnancy Advisory Service

EllaOne manufacturer HRA Pharma supports the British Pregnancy Advisory Service's (BPAS') calls to scrap mandatory consultations for emergency contraceptives by switching these medicines from pharmacy-only to general sales list status. 

Related Content

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel